Skip to main content
SpringerLink
Log in

Complications of Endovascular Treatment of Peripheral Congenital Vascular Malformations

  • Chapter
  • First Online:
Congenital Vascular Malformations

  • 1212 Accesses

Abstract

Interventional procedures in the management of congenital vascular malformations (CVM) have enjoyed rapid advances in the past two decades. This has followed advances in related fields such as diagnostic ultrasound, magnetic resonance imaging (MRI), histopathology and molecular genetics. Endovascular procedures using a variety of embolic and sclerosing agents have replaced surgery as the preferred treatment option. The new interventional techniques have shown superior results to excisional surgery and have significantly reduced the need for aggressive surgical procedures. Interventional techniques are performed under fluoroscopic and/or duplex ultrasound (DUS) guidance, and advances in these imaging modalities have tremendously helped with a better management of vascular anomalies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Upton J, Taghinia A. Special considerations in vascular anomalies: operative management of upper extremity lesions. Clin Plast Surg. 2011;38:143–51.

    Article  PubMed  Google Scholar 

  2. Parsi K, Kossard S. Multiple hereditary glomangiomas: successful treatment with sclerotherapy. Australas J Dermatol. 2002;43:43–7.

    Article  PubMed  Google Scholar 

  3. Wong K, Chen T, Connor DE, Behnia M, Parsi K. Basic physiochemical and rheological properties of detergent sclerosants. Phlebology. 2015;30:339–49.

    Article  PubMed  Google Scholar 

  4. Connor DE, Cooley-Andrade O, Goh WX, Ma DD, Parsi K. Detergent sclerosants are deactivated and consumed by circulating blood cells. Eur J Vasc Endovasc Surg. 2015;49:426–31.

    Article  CAS  PubMed  Google Scholar 

  5. Cavezzi A, Parsi K. Complications of foam sclerotherapy. Phlebology. 2012;27(Suppl 1):46–51.

    Article  PubMed  Google Scholar 

  6. Kim B, Somia N, Pereira J, Parsi K. Open access sclerotherapy: an alternative technique to treat complex venous malformations. Dermatol Surg. 2014;40:802–5.

    CAS  PubMed  Google Scholar 

  7. Donnelly LF, Bisset 3rd GS, Adams DM. Marked acute tissue swelling following percutaneous sclerosis of low-flow vascular malformations: a predictor of both prolonged recovery and therapeutic effect. Pediatr Radiol. 2000;30:415–9.

    Article  CAS  PubMed  Google Scholar 

  8. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol. 2004;15:431–45.

    Article  PubMed  Google Scholar 

  9. Saitta P, Krishnamurthy K, Brown LH. Bleomycin in dermatology: a review of intralesional applications. Dermatol Surg. 2008;34:1299–313.

    CAS  PubMed  Google Scholar 

  10. Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg. 1994;29:784–5.

    Article  CAS  PubMed  Google Scholar 

  11. Park HS, Do YS, Park KB, et al. Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations. Eur Radiol. 2016;26:1301–10.

    Article  PubMed  Google Scholar 

  12. Yamaki T, Nozaki M, Sakurai H, et al. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg. 2008;47:578–84.

    Article  PubMed  Google Scholar 

  13. Parsi K, Hannaford P. Intra-arterial injection of sclerosants: report of three cases treated with systemic steroids. Phlebology. 2015;31:241–50.

    Article  PubMed  Google Scholar 

  14. Tran D, Parsi K. Veno-arteriolar reflex vasospasm of small saphenous artery complicating sclerotherapy of the small saphenous vein. Austr N Z J Phleb. 2007;10:29–32.

    Google Scholar 

  15. Lee KB, Kim DI, Oh SK, et al. Incidence of soft tissue injury and neuropathy after embolo/sclerotherapy for congenital vascular malformation. J Vasc Surg. 2008;48:1286–91.

    Article  PubMed  Google Scholar 

  16. Tan KT, Simons ME, Rajan DK, Terbrugge K. Peripheral high-flow arteriovenous vascular malformations: a single-center experience. J Vasc Interv Radiol. 2004;15:1071–80.

    Article  PubMed  Google Scholar 

  17. Shergill A, John P, Amaral JG. Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy. Pediatr Radiol. 2012;42:1080–8.

    Article  PubMed  Google Scholar 

  18. Kirby JS, Miller CJ. Intralesional chemotherapy for nonmelanoma skin cancer: a practical review. J Am Acad Dermatol. 2010;63:689–702.

    Article  CAS  PubMed  Google Scholar 

  19. Horbach SE, Rigter IM, Smitt JH, et al. Intralesional bleomycin injections for vascular malformations: a systematic review and meta-analysis. Plast Reconstr Surg. 2016;137:244–56.

    Article  CAS  PubMed  Google Scholar 

  20. Ogita S, Tsuto T, Nakamura K, et al. OK-432 therapy for lymphangioma in children: why and how does it work? J Pediatr Surg. 1996;31:477–80.

    Article  CAS  PubMed  Google Scholar 

  21. Karavelioglu A, Temucin CM, Tanyel FC, et al. Sclerotherapy with bleomycin does not adversely affect facial nerve function in children with cervicofacial cystic lymphatic malformation. J Pediatr Surg. 2010;45:1627–32.

    Article  PubMed  Google Scholar 

  22. Marrocco-Trischitta MM, Guerrini P, Abeni D, Stillo F. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation. Dermatol Surg. 2002;28:153–5.

    PubMed  Google Scholar 

  23. Cordero-Schmidt G, Wallenstein MB, Ozen M, et al. Pulmonary hypertensive crisis following ethanol sclerotherapy for a complex vascular malformation. J Perinatol. 2014;34:713–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Park HS, Do YS, Park KB, et al. Ethanol embolotherapy of hand arteriovenous malformations. J Vasc Surg. 2011;53:725–31.

    Article  PubMed  Google Scholar 

  25. Do YS, Kim YW, Park KB, et al. Endovascular treatment combined with emboloscleorotherapy for pelvic arteriovenous malformations. J Vasc Surg. 2012;55:465–71.

    Article  PubMed  Google Scholar 

  26. Do YS, Park KB, Park HS, et al. Extremity arteriovenous malformations involving the bone: therapeutic outcomes of ethanol embolotherapy. J Vasc Interv Radiol. 2010;21:807–16.

    Article  PubMed  Google Scholar 

  27. Lee BB, Baumgartner I, Berlien HP, et al. Consensus Document of the International Union of Angiology (IUA)-2013. Current concept on the management of arterio-venous management. Int Angiol. 2013;32:9–36.

    CAS  PubMed  Google Scholar 

  28. Park KB, Do YS, Kim DI, et al. Predictive factors for response of peripheral arteriovenous malformations to embolization therapy: analysis of clinical data and imaging findings. J Vasc Interv Radiol. 2012;23:1478–86.

    Article  PubMed  Google Scholar 

  29. Kim JS, Nam MH, Do YS, et al. Efficacy of milrinone versus nitroglycerin in controlling pulmonary arterial hypertension induced by intravenous injections of absolute ethanol in anesthetized dogs. J Vasc Interv Radiol. 2010;21:882–7.

    Article  PubMed  Google Scholar 

  30. Ko JS, Kim JA, Do YS, et al. Prediction of the effect of injected ethanol on pulmonary arterial pressure during sclerotherapy of arteriovenous malformations: relationship with dose of ethanol. J Vasc Interv Radiol. 2009;20:39–45. quiz 45

    Article  PubMed  Google Scholar 

  31. Shin BS, Do YS, Cho HS, et al. Effects of repeat bolus ethanol injections on cardiopulmonary hemodynamic changes during embolotherapy of arteriovenous malformations of the extremities. J Vasc Interv Radiol. 2010;21:81–9.

    Article  PubMed  Google Scholar 

  32. Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma. J Pediatr Surg. 1995;30:1282–7.

    Article  CAS  PubMed  Google Scholar 

  33. Bush RG, Derrick M, Manjoney D. Major neurological events following foam sclerotherapy. Phlebology. 2008;23:189–92.

    Article  CAS  PubMed  Google Scholar 

  34. Rabe E, Breu FX, Cavezzi A, et al. European guidelines for sclerotherapy in chronic venous disorders. Phlebology. 2014;29:338–54.

    Article  CAS  PubMed  Google Scholar 

  35. Lv X, Wu Z, Jiang C, et al. Complication risk of endovascular embolization for cerebral arteriovenous malformation. Eur J Radiol. 2011;80:776–9.

    Article  PubMed  Google Scholar 

  36. Hartmann A, Pile-Spellman J, Stapf C, et al. Risk of endovascular treatment of brain arteriovenous malformations. Stroke. 2002;33:1816–20.

    Article  CAS  PubMed  Google Scholar 

  37. Yun WS, Kim YW, Lee KB, et al. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging. J Vasc Surg. 2009;50:581–9. 589 e581

    Article  PubMed  Google Scholar 

  38. Parsi K, Exner T, Connor DE, et al. The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro. Eur J Vasc Endovasc Surg. 2008;36:216–23.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Prof. BB Lee for providing the figures used in this chapter.

Author information

Authors and Affiliations

  1. Department of Dermatology, St. Vincent’s Hospital, University of New South Wales, Sydney, Australia

    Kurosh Parsi

  2. Sungkyunkwan University, School of Medicine and Samsung Medical Center, Seoul, South Korea

    Young Soo Do

Authors
  1. Kurosh Parsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Young Soo Do
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Kurosh Parsi or Young Soo Do .

Editor information

Editors and Affiliations

  1. Division of Vascular Surgery, Department of Surgery, Samsung Medical Center, Seoul, Korea (Republic of)

    Young-Wook Kim

  2. Professor of Surgery and Director, Center for the Lymphedema and Vascular Malformations, George Washington University, Washington, DC, USA

    Byung-Boong Lee

  3. Swedish Medical Center, Vascular malformation Center, Englewood, Colorado, USA

    Wayne F. Yakes

  4. Department of Radiology, Samsung Medical Center, Seoul, Korea (Republic of)

    Young-Soo Do

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Parsi, K., Do, Y.S. (2017). Complications of Endovascular Treatment of Peripheral Congenital Vascular Malformations. In: Kim, YW., Lee, BB., Yakes, W., Do, YS. (eds) Congenital Vascular Malformations. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46709-1_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-46709-1_35

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-46708-4

  • Online ISBN: 978-3-662-46709-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation